Does treatment with hydroxychloroquine or chloroquine lead to QTc prolongation in children?

Hydroxychloroquine and chloroquine are drugs with a long history of therapeutic use in the prevention of both rheumatologic and infectious diseases. However, the cardiotoxic potential of therapy with these medications, particularly in children, remains a noted concern. This review aims to identify w...

Full description

Saved in:
Bibliographic Details
Published in:Progress in pediatric cardiology 2022-03, Vol.64, p.101465, Article 101465
Main Authors: Parthasarathy, Prasiddha, Shaikh, Haniah, Ryan, Paul MacDaragh, Mondal, Tapas
Format: Article
Language:English
Subjects:
Cardiology
Chloroquine
Hydroxychloroquine
Pediatrics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hydroxychloroquine and chloroquine are drugs with a long history of therapeutic use in the prevention of both rheumatologic and infectious diseases. However, the cardiotoxic potential of therapy with these medications, particularly in children, remains a noted concern. This review aims to identify whether treatment with hydroxychloroquine or chloroquine results in clinically meaningful QTc prolongation and increased risk of arrhythmia in comparison to baseline risk in the pediatric population. Out of the combined 65 children from the four included chloroquine studies with normal pre-treatment QTc intervals, 13 (20%) experienced clinically defined QTc prolongation (i.e., >440–500 ms). Of the combined 56 patients who were administered hydroxychloroquine across four studies, 5 (8.9%) patients experienced clinically defined QT or QTc prolongation. Such effects were found to be most prominent in the initial days of treatment. While QTc prolongation was reported in the majority of studies analyzed, the isolated medication effect is difficult to establish in the absence of placebo arms and randomization procedures. Although hydroxychloroquine and chloroquine may prolong the QT interval in children, there is little evidence to suggest that it commonly prolongs it to a clinically relevant or arrhythmogenic degree with short-term treatment. •Pediatric patients treated with hydroxychloroquine & chloroquine are at risk of QT prolongation.•In the included studies, at therapeutic doses QT was not prolonged to an arrhythmogenic degree.•Caution must be exercised in using hydroxychloroquine & chloroquine in pediatric patients.
ISSN:1058-9813
1558-1519
DOI:10.1016/j.ppedcard.2021.101465